A weight loss doctor walks through retatrutide, which she calls the most anticipated obesity drug currently in clinical trials.
Recap by typeshit. Full story at Bazgha Khalid, MD.
A short Philstar Life item on PIONEER 8, a trial of oral semaglutide. The material gives only the title, so tap through for the details.
She points out one trial enrolled people with diabetes and the other excluded them, so the results aren't a head to head match.
Researchers built a topology-guided add-on to AlphaFold3 aimed at the threaded tail that trips up lasso peptide structure prediction.
Gannan Medical University researchers screened 6,000 candidates from Hypsizygus marmoreus and found peptides that may help cut sodium without losing flavor.
Peptides have become a favorite of longevity and optimization podcasts, and USA TODAY looks at where those claims go wrong.
The Pennsylvania county is funding a study into whether the GLP-1 drug can help people with substance use disorders.
Loading…